trending Market Intelligence /marketintelligence/en/news-insights/trending/jg3peqir82xwlprb0d-lda2 content esgSubNav
In This List

CytoDyn raises $9.9M through private placement

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


CytoDyn raises $9.9M through private placement

Vancouver, Wash.-based CytoDyn Inc. raised approximately $9.9 million via the sale of 19,823,260 units at 50 cents apiece.

Each unit was made up of a common share and a warrant to purchase an additional stock at 75 cents each.

CytoDyn is developing treatments for HIV.